Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Heartware International Inc. : ASX Appendix 3B - Grant and Cancellation of Options

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/10/2013 | 08:09am CET

Manager of Company Announcements

ASX Limited

Level 6

20 Bridge Street

SYDNEY NSW 2000

Dear Sir / Madam

Equity Grants/Cancellations

7 January 2013

BY E-LODGEMENT

Please see the attached ASX Appendix 3B in relation to the annual grant of equity to employees

under the Company's 2012 Incentive Award Plan for the purposes of inducement and retention.

Please be advised that the Company has also cancelled 6,250 restricted stock units granted under

the Company's 2008 Stock Incentive Plan.

Yours faithfully,


Lawrence J. Knopf

General Counsel & Company Secretary

HeartWare International, Inc.

Appendix 3B

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

HeartWare International, Inc.

ARBN

132 897 762

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).


1 +Class of +securities issued or to be issued

Restricted stock units issued under the 2012

Incentive Award Plan


2 Number of +securities issued or to be issued (if known) or maximum number which may be issued

170,900 restricted stock units issued under the

2012 Incentive Award Plan

+ See chapter 19 for defined terms.

1/1/2003 Appendix 3B Page 1


3 Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)
165,400 restricted stock units (unquoted). Each restricted stock unit is issued for no monetary consideration and on vesting entitles the holder to be issued one share of common stock for no monetary consideration and otherwise each restricted stock unit is issued in accordance with the Company's 2012
Incentive Award Plan. Vesting shall occur in four equal annual tranches commencing on the first anniversary of the 20 December 2012 grant date.
5,000 restricted stock units (unquoted). Each restricted stock unit is issued for no monetary consideration and on vesting entitles the holder to be issued one share of common stock for no monetary consideration and otherwise each restricted stock unit is issued in accordance with the Company's 2012 Incentive Award Plan. Vesting shall occur in three equal annual tranches commencing on the first anniversary of the 20
December 2012 grant date.
500 restricted stock units (unquoted). Each restricted stock unit is issued for no monetary consideration and on vesting entitles the holder to be issued one share of common stock for no monetary consideration and otherwise each restricted stock unit is issued in accordance with the Company's 2012 Incentive Award Plan. Vesting shall occur in four equal annual tranches commencing on the first anniversary of the 5 December
2012 grant date.

4 Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?
If the additional securities do not rank equally, please state:

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
11:19pDJMORGAN STANLEY : CEO Gets 7% Raise; Goldman Trims Stock-Pay for Some Executives
11:19p BIOPTIX, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
11:18p INTERSECT ENT, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
11:16p BANK OF NOVA SCOTIA : S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
11:16pDJNEWS HIGHLIGHTS : Top Global Markets News of the Day
11:16pDJNEWS HIGHLIGHTS : Top Company News of the Day
11:16p J M SMUCKER : Declares Dividend
11:16p CONSTELLATION SOFTWARE INC. : Announces Annual Interest Rate for Series 1 Debentures
11:15p INFINITY DEVELOPMENT : Notice of annual general meeting
11:15p INFINITY DEVELOPMENT : Proposed payment of final dividend and closure of register of members
Latest news
Advertisement
Hot News 
12.40%SYNTHOMER : Chemicals maker Synthomer sees 2016 profit ahead of estimates
-11.28%Bristol-Myers lung cancer delay slams shares, keeps Merck in lead
-6.24%European shares ease ahead of Trump inauguration
-2.18%GENERAL ELECTRIC : Nason, former Treasury official, being vetted for Fed role - sources
7.87%SDL : Translation software firm SDL sees full year results ahead of market expectations
Most Read News
09:33a BLACKROCK : Fears of economic 'race to bottom', strong dollar in Davos
02:05p GENERAL ELECTRIC : GE looks for sharp cut in corporate tax rate under Trump
12:16aDJNEWS HIGHLIGHTS : Top Energy News of the Day
05:54a WESTERN UNION : admits to aiding wire fraud, to pay $586 million
01/19 TESLA MOTORS : U.S. regulator finds no evidence of defects after Tesla death probe
Most recommended articles
01/17DJS&P 500, Nasdaq Futures -- Technical Analysis
05:09p MORGAN STANLEY : CEO James Gorman's 2016 pay up 7 percent to $22.5 million
05:09p JAMES GORMAN : Morgan Stanley CEO James Gorman's 2016 pay up 7 pct to $22.5 million
05:00pDJCorn Rises on Fund Buying; Soybeans Decline
04:58pDJCorrection to inauguration donors article